No Data
No Data
Merck's male HPV vaccine has been approved domestically for the first time. Industry insiders believe this will promote the future approval of domestic products under development.
① Gardasil has become the first and currently the only approved HPV vaccine for men in China. ② Industry experts believe that the approval of the new indication is a new exploration in terms of pharmacological principles and other aspects. ③ Currently, companies such as Kang Li Wei Shi and Beijing Wantai Biological Pharmacy Enterprise have made arrangements in this field.
Open up new markets! Merck (MRK.US) Gardasil becomes the first approved male HPV vaccine in China.
After the vaccination craze among women gradually subsides, it opens up an undeveloped new market for this pharmaceutical giant in the USA.
Express News | Merck China: Chinese National Medical Products Administration Has Approved Hpv Vaccine for Men
Truist Financial Downgrades Merck & Co(MRK.US) to Hold Rating, Cuts Target Price to $110
Tuesday Market Pulls Back After Nvidia All Time High | Wall Street Today
Bullish Outlook On Instil Bio's Investigational Cancer Drug: Jefferies Sees Over 300% Stock Upside
Unlock the Full List